Differential neuroproteomic and systems biology analysis of spinal cord injury

Molecular and Cellular Proteomics

Volumn 15, Issue 7, 2016, Pages 2379-2395

  Moghieb, Ahmed ^a,b,c   Bramlett, Helen M ^d,e   Das, Jyotirmoy H ^a,f   Yang, Zhihui ^a,b   Selig, Tyler ^a   Yost, Richard A ^c   Wang, Michael S ^d,e   Dalton Dietrich, W ^d,e   Wang, Kevin K W ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Florida   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 4 FAMILY MEMBER A1; AMINOACYLASE 1A; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; BIOLOGICAL MARKER; CATHEPSIN D; ELONGATION FACTOR 2; EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; FATTY ACID SYNTHASE; LIPOCORTIN 1; LIPOCORTIN 2; LOC367586 PROTEIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; NEURON SPECIFIC ENOLASE; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE 1; OXIDOREDUCTASE; PEROXIREDOXIN 2; PHOSPHOGLUCOMUTASE; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15; PROTEIN; PROTEOME; PYROPHOSPHATE; PYRUVATE KINASE PKM; STATHMIN 1; TIN1 PROTEIN; TRANSFERRIN; TRANSKETOLASE; TRIOSEPHOSPHATE ISOMERASE 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANION EXCHANGE CHROMATOGRAPHY; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CELL INVASION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FAMILY; FEMALE; HUMAN; IMMUNOBLOTTING; NEUROLOGY; NEUROPROTEOMIC; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SHAM PROCEDURE; SPINAL CORD INJURY; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; UPREGULATION; AGED; ANIMAL; CAUDA EQUINA; DISEASE COURSE; DISEASE MODEL; MALE; METABOLISM; MIDDLE AGED; PROCEDURES; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; ANIMALS; BIOMARKERS; CAUDA EQUINA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; MALE; MIDDLE AGED; PROTEIN INTERACTION MAPS; PROTEOMICS; RATS; SPINAL CORD INJURIES; SYSTEMS BIOLOGY; UP-REGULATION;

EID: 84977264783     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M116.058115     Document Type: Article

References (59)

1. Cortez, R., and Levi, A. D. (2008) Acute spinal cord injury. Curr. Treat Options Neurol. 9, 115-125
2. Gil-Dones, F., Alonso-Orgaz, S., Avila, G., Martin-Rojas, T., Moral-Darde, V., Barroso, G., Vivanco, F., Scott-Taylor, J., and Barderas, M. G. (2009) An Optimal Protocol to Analyze the Rat Spinal Cord Proteome. BMI 2009, 135-164
3. The Christopher & Dana Reeve Foundation (2008) Paralysis 2008, 1-48
4. Baptiste, D. C., and Fehlings, M. G. (2006) Pharmacological approaches to repair the injured spinal cord. J. Neurotrauma 23, 318-334
5. Yu, C.-G., and Geddes, J. W. (2007) Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury. Neurochem. Res. 32, 2046-2053
6. Kwon, B. K., Casha, S., Hurlbert, R. J., and Yong, V. W. (2011) Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin. Chem. Lab. Med. 49, 425-433
7. Lubieniecka, J. M., Streijger, F., Lee, J. H. T., Stoynov, N., Liu, J., Mottus, R., Pfeifer, T., Kwon, B. K., Coorssen, J. R., Foster, L. J., Grigliatti, T. A., and Tetzlaff, W. (2011) Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats. PLoS ONE 6, e19247
8. Holly, L. T., Freitas, B., McArthur, D. L., and Salamon, N. (2009) Proton magnetic resonance spectroscopy to evaluate spinal cord axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine 10, 194-200
9. Sajja, B. R., Wolinsky, J. S., and Narayana, P. A. (2009) Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin. N. Am. 19, 45-58
10. Carpentier, A., Galanaud, D., Puybasset, L., Muller, J.-C., Lescot, T., Boch, A.-L., Riedl, V., Riedl, V., Cornu, P., Coriat, P., Dormont, D., and van Effenterre, R. (2006) Early morphologic and spectroscopic magnetic resonance in severe traumatic brain injuries can detect "invisible brain stem damage" and predict "vegetative states". J. Neurotrauma 23, 674-685
11. Qian, J., Herrera, J. J., and Narayana, P. A. (2010) Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology. J. Neurotrauma 27, 599-610
12. JOHANN, D. J., JR., MCGUIGAN, M. D., PATEL, A. R., TOMOV, S., ROSS, S., Conrads, T. P., Veenstra, T. D., FISHMAN, D. A., WHITELEY, G. R., PETRICOIN, E. F., III, and LIOTTA, L. A. (2004) Clinical Proteomics and Biomarker Discovery. Ann. N.Y. Acad. Sci. 1022, 295-305
13. Paul, D., Kumar, A., Gajbhiye, A., Santra, M. K., and Srikanth, R. (2013) Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. BioMed. Research International 2013, 783131-783131
14. Davidsson, P., and Sjö gren, M. (2005) The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis. Markers 21, 81-92
15. Paul, D., Kumar, A., Gajbhiye, A., Santra, M. K., and Srikanth, R. (2013) Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. BioMed Research International 2013, 783131-783131
16. Ding, Q., Wu, Z., Guo, Y., Zhao, C., Jia, Y., Kong, F., Chen, B., Wang, H., Xiong, S., Que, H., Jing, S., and Liu, S. (2006) Proteome analysis of up-regulated proteins in the rat spinal cord induced by transection injury. Proteomics 6, 505-518
17. Issaq, H. J., Chan, K. C., Janini, G. M., Conrads, T. P., and Veenstra, T. D. (2005) Multidimensional separation of peptides for effective proteomic analysis. J. Chromatography B 817, 35-47
18. Tissot Lion, J. D. N. (2008) Clinical Proteomics: From Diagnosis to Therapy. By J. E. Van Eyk and M. J. Dunn (Eds.). Proteomics 8, 1945-1945
19. Yu, W., Li, Y., Deng, C., and Zhang, X. (2006) Comprehensive two-dimen-sional separation in coupling of reversed-phase chromatography with capillary isoelectric focusing followed by MALDI-MS identification using on-target digestion for intact protein analysis. Electrophoresis 27, 2100-2110
20. Sheng, S., Chen, D., and Van Eyk, J. E. (2006) Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol. Cell. Proteomics 5, 26-34
21. Sheng, S., Chen, D., and Van Eyk, J. E. (2006) Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol. Cell. Proteomics 5, 26-34
22. Kang, S. K., So, H. H., Moon, Y. S., and Kim, C. H. (2006) Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS. Proteomics 6, 2797-2812
23. Tsai, M. C, Shen, L. F., Kuo, H. S., Cheng, H., and Chak, K. F. (2008) Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach. Mol. Cell. Proteomics 7, 1668-1687
24. Yan, X., Liu, J., Luo, Z., Ding, Q., Mao, X., Yan, M., Yang, S., Hu, X., Huang, J., and Luo, Z. (2010) Proteomic profiling of proteins in rat spinal cord induced by contusion injury. Neurochem. Int. 56, 971-983
25. Cao, F., Yang, X.-F., Liu, W.-G., Hu, W.-W., Li, G., Zheng, X.-J., Shen, F., Zhao, X.-Q., and Lv, S.-T. (2008) Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury. J. Clin. Neurosci. 15, 541-544
26. Guez, M., Hildingsson, C, Rosengren, L., Karlsson, K., and Toolanen, G. (2003) Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma. J. Neurotrauma 20, 853-858
27. Kwon, B. K., Stammers, A. M. T., Belanger, L. M., Bernardo, A., Chan, D., Bishop, C. M., Slobogean, G. P., Zhang, H., Umedaly, H., Giffin, M., Street, J., Boyd, M. C, Paquette, S. J., Fisher, C. G., and Dvorak, M. F. (2010) Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 27, 669-682
28. Ma, J., Novikov, L. N., Karlsson, K., Kellerth, J. O., and Wiberg, M. (2001) Plexus avulsion and spinal cord injury increase the serum concentration of S-100 protein: an experimental study in rats. Scand. J. Plast. Reconstr. Surg. Hand Surg. 35, 355-359
29. Zhang, B., Huang, Y., Su, Z., Wang, S., Wang, S., Wang, J., Wang, A., and Lai, X. (2011) Neurological, functional, and biomechanical characteristics after high-velocity behind armor blunt trauma of the spine. J. Trauma: Injury, Infection, and Critical Care 71, 1680-1688
30. Loy, D. N., Sroufe, A. E., Pelt, J. L., Burke, D. A., and Cao, Q. (2005) Serum biomarkers for experimental acute spinal cord injury: Rapid elevation of neuron-specific enolase and S-100/3. Neurosurgery 56, 391-397
31. Shaw, G., Yang, C, Ellis, R., Anderson, K., Parker Mickle, J., Scheff, S., Pike, B., Anderson, D. K., and Howland, D. R. (2005) Hyperphosphory-lated neurofilament NF-H is a serum biomarker of axonal injury. Biochem. Biophys. Res. Commun. 336, 1268-1277
32. Springer, J. E., Azbill, R. D., Kennedy, S. E., George, J., and Geddes, J. W. (1997) Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreat-ment. J. Neurochem. 69, 1592-1600
33. Zhang, S. X., Underwood, M., Landfield, A., Huang, F. F., Gison, S., and Geddes, J. W. (2000) Cytoskeletal disruption following contusion injury to the rat spinal cord. J. Neuropathol. Exp. Neurol. 59, 287-296
34. Pouw, M. H., Hosman, A. J. F., van Middendorp, J. J., Verbeek, M. M., Vos, P. E., and van de Meent, H. (2009) Biomarkers Spinal Cord Injury 47, 519-525
35. Okon, E. B., Streijger, F., Lee, J. H. T., Anderson, L. M., Russell, A. K., and Kwon, B. K. (2013) Intraparenchymal microdialysis after acute spinal cord injury reveals differential metabolic responses to contusive versus compressive mechanisms of injury. J. Neurotrauma 30, 1564-1576
36. Stammers, A. T., Liu, J., and Kwon, B. K. (2012) Expression of inflammatory cytokines following acute spinal cord injury in a rodent model. J. Neurosci. Res. 90, 782-790
37. Kitano, H. (2002) Systems biology: a brief overview. Science 295, 1662-1664
38. Zhang, Z., Larner, S. F., Kobeissy, F., Hayes, R. L., and Wang, K. K. W. (2010) Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury. Methods Mol. Biol. 662, 317-329
39. Kobeissy, F. H., Guingab-Cagmat, J. D., Razafsha, M., O'Steen, L., Zhang, Z., Hayes, R. L., Chiu, W.-T., and Wang, K. K. W. (2011) Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research. PM & R 3, S139-S147
40. Feala, J. D., AbdulHameed, M. D. M., Yu, C, Dutta, B., Yu, X., Schmid, K., Dave, J., Tortella, F., and Reifman, J. (2013) Systems Biology Approaches for Discovering Biomarkers for Traumatic Brain Injury. J. Neu-rotrauma 30, 1101-1116
41. Kobeissy, F. H., Ottens, A. K., Zhang, Z., Liu, M. C., Denslow, N. D., Dave, J. R., Tortella, F. C., Hayes, R. L., Wang, K. K., Kobeissy, F. H., Ottens, A. K., Zhang, Z., Liu, M. C., Denslow, N. D., Dave, J. R., Tortella, F. C., Hayes, R. L., and Wang, K. K. W. (2006) Novel differential neuroproteom-ics analysis of traumatic brain injury in rats. Mol. Cell. Proteomics 5, 1887-1898
42. Pinzon, A., Marcillo, A., Pabon, D., Bramlett, H. M., Bunge, M. B., and Dietrich, W. D. (2008) A re-assessment of erythropoietin as a neuropro-tective agent following rat spinal cord compression or contusion injury. Exp. Neurol. 213, 129-136
43. Pinzon, A., Marcillo, A., Quintana, A., Stamler, S., Bunge, M. B., Bramlett, H. M., and Dietrich, W. D. (2008) A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res. 1243, 146-151
44. Gruner, J. A. (1992) A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9, 123-128
45. Agrawal, G., Kerr, C., Thakor, N. V., and All, A. H. (2010) Characterization of graded multicenter animal spinal cord injury study contusion spinal cord injury using somatosensory-evoked potentials. Spine 35, 1122-1127
46. Flint, J., Dutta, S., Johnson, E., Wang, K. K., Pike, B. R., and Hayes, R. L. (2001) Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 78, 1297-1306
47. Vizcaíno, J. A., Deutsch, E. W., Wang, R., Csordas, A., Reisinger, F., Ríos, D., Dianes, J. A., Sun, Z., Farrah, T., Bandeira, N., Binz, P.-A., Xenarios, I., Eisenacher, M., Mayer, G., Gatto, L., Campos, A., Chalkley, R. J., Kraus, H.-J., Albar, J. P., Martinez-Bartolomé, S., Apweiler, R., Omenn, G. S., Martens, L., Jones, A. R., and Hermjakob, H. (2014) ProteomeX-change provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226
48. Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K., Robertson, C. S., Hayes, R. L., Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K. W., Robertson, C. S., and Hayes, R. L. (2007) Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366
49. Reis, F. M., Esteves, A. M., Tufik, S., and de Mello, M. T. (2010) ORIGINAL ARTICLEPlasma iron levels appraised 15 days after spinal cord injury in a limb movement animal model. Spinal Cord 49, 361-364
50. Banik, N. L., Matzelle, D. C., Gantt-Wilford, G., Osborne, A., and Hogan, E. L. (1997) Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752, 301-306
51. Sharif, A., Renault, F., Beuvon, F., Castellanos, R., Canton, B., Barbeito, L., Junier, M. P., and Chneiweiss, H. (2004) The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopula-tions of astrocytes and neurons throughout the adult mouse brain. NSC 126, 263-275
52. Allard, L., Burkhard, P. R., Lescuyer, P., Burgess, J. A., Walter, N., Hoch-strasser, D. F., and Sanchez, J.-C. (2005) PARK7 and nucleoside diphos-phate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem. 51, 2043-2051
53. Wang, K. K. W. (2000) Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26
54. Liu, M. C., Akinyi, L., Scharf, D., Mo, J., Larner, S. F., Muller, U., Oli, M. W., Zheng, W., Kobeissy, F., Papa, L., Lu, X.-C., Dave, J. R., Tortella, F. C., Hayes, R. L., and Wang, K. K. W. (2010) Ubiquitin C-terminal hydro-lase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur. J. Neurosci. 31, 722-732
55. Boja, E. S., and Rodriguez, H. (2014) Proteogenomic convergence for understanding cancer pathways and networks. Clin. Proteomics 11, 22
56. Wang, E. (2013) Understanding genomic alterations in cancer genomes using an integrative network approach. Cancer Lett. 340, 261-269
57. Kobeissy, F. H., Sadasivan, S., Liu, J., Gold, M. S., and Wang, K. K. W. (2008) Psychiatric research: psychoproteomics, degradomics and systems biology. Expert Rev. Proteomics 5, 293-314
58. Fekete, T., Zach, N., Mujica-Parodi, L. R., and Turner, M. R. (2013) Multiple kernel learning captures a systems-level functional connectivity bio-marker signature in amyotrophic lateral sclerosis. PLoS ONE 8, e85190
59. Kotelnikova, E., Bernardo-Faura, M., Silberberg, G., Kiani, N. A., Messinis, D., Melas, I. N., Artigas, L., Schwartz, E., Mazo, I., Masso, M., Alexo-poulos, L. G., Mas, J. M., Olsson, T., Tegner, J., Martin, R., Zamora, A., Paul, F., Saez-Rodriguez, J., and Villoslada, P. (2015) Signaling networks in MS: a systems-based approach to developing new pharmacological therapies. Multiple Sclerosis J. 21, 138-146